| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.20B | 43.20B | 33.88B | 25.51B | 20.42B | 16.18B |
| Gross Profit | 37.41B | 37.41B | 28.81B | 21.83B | 17.91B | 14.19B |
| EBITDA | 1.43B | 1.54B | 1.87B | 856.00M | 1.71B | 1.10B |
| Net Income | 423.00M | 424.00M | 953.00M | -141.00M | 857.00M | 182.00M |
Balance Sheet | ||||||
| Total Assets | 47.98B | 47.98B | 37.59B | 31.20B | 26.29B | 24.31B |
| Cash, Cash Equivalents and Short-Term Investments | 31.17B | 31.17B | 24.87B | 21.11B | 15.43B | 12.39B |
| Total Debt | 3.57B | 3.57B | 4.48B | 3.40B | 3.02B | 2.16B |
| Total Liabilities | 31.95B | 31.95B | 22.82B | 18.01B | 14.20B | 11.73B |
| Stockholders Equity | 15.92B | 15.92B | 14.64B | 13.12B | 12.09B | 12.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.42B | 5.27B | 3.65B | 2.65B | 2.74B |
| Operating Cash Flow | 0.00 | 9.65B | 5.48B | 3.85B | 3.12B | 3.01B |
| Investing Cash Flow | 0.00 | -2.55B | -3.18B | 1.36B | -1.01B | -551.42M |
| Financing Cash Flow | 0.00 | -654.00M | 1.43B | 523.00M | 909.00M | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥251.00B | 21.61 | ― | 2.67% | 9.10% | 14.67% | |
74 Outperform | ¥121.77B | 23.16 | ― | 2.66% | 5.22% | -6.62% | |
72 Outperform | ¥150.94B | 23.78 | ― | 0.91% | 26.47% | 142.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | ¥213.47B | 194.30 | ― | ― | 27.65% | 96.11% | |
51 Neutral | ¥199.40B | 143.84 | ― | ― | 31.57% | ― | |
41 Neutral | €240.21B | -38.85 | -19.16% | ― | 19.57% | -16.67% |